Legislation

Five things for pharma marketers to know: Thursday, July 13, 2017

Five things for pharma marketers to know: Thursday, July 13, 2017

By

AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge

DTC Report 2016: Gut Check

DTC Report 2016: Gut Check

By

DTC is facing a new test from physicians and politicians. Here's why critics fear a deluge, and how they're pushing back.

Sen. Sanders joins drug-pricing fray

Sen. Sanders joins drug-pricing fray

By

The presidential candidate is the latest critic of current laws that prohibit the government from negotiating drug prices for Medicare Part D.

House expected to vote on 21st Century Cures

House expected to vote on 21st Century Cures

By

The legislation would allow drugmakers to share information about their products beyond what is included on the FDA-approved label.